Posted by Michael Wonder on 13 Jan 2020
Drug makers test new ways to pay for six figure treatments
13 January 2020 - Public pressure, insurer pushback and better data are driving drug companies to tinker with how they get paid.
Drug makers are experimenting with new ways to get paid for their most-expensive medicines, as resistance to escalating prices builds and improvements are made in collecting and analysing patient data.
Now that six-figure price tags are common, drug companies are finding creative ways to get reimbursed, from instalment plans to subscriptions to more complex value-based contracts that tie payment to when a drug helps a patient. For years, pharmaceutical companies would typically set a price for a drug and then get paid per pill sold at that price, less any negotiated rebates.
